drugset
drugset / Trial / NCT07364877

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

NCT07364877 ↗

Phase 1 Enrolling by invitation 38 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelBasic science

Summary

Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S

Timeline

Start
2025-12-28
Primary completion
2026-03-19
Completion
2026-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject DW4421 Unknown — —
Subject DW4421S Unknown — —

Indications

No indication recorded.